Teva Pharm CEO says not worried about US tariffs on drugs sector
ReutersJan 29, 2025 2:47 PM
JERUSALEM, Jan 29 (Reuters) - Teva Pharmaceutical Industries TEVA.TA is not overly concerned about U.S. President Donald Trump potentially imposing tariffs on drugs since many medicines are already made in the United States, its chief executive said on Wednesday.
Tariffs "may take time to come to this sector because if you stop pharmaceuticals from abroad, you have to have them made in the U.S. to make a substitution," Teva CEO Richard Francis told Reuters after the Israeli drugmaker issued fourth-quarter results.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
China July Money Supply Commentary: M2 Growth Rises More Than Expected
The relatively large increase in M2 mainly stems from two factors: first, the impact of a low base formed by the relatively low growth rate of M2 in the same period last year; second, the resolution of debts has promoted the improvement of corporate capital flows.TradingKey
14 hours ago
Applied Materials Q3 Earnings: AI Demand Soars, but Cautious Guidance Triggers After-Hours Selloff
TradingKey - Applied Materials, Inc. (NASDAQ: AMAT) announced its Q3 FY2025 earnings on August 14, 2025, after market close, reporting strong revenue fueled by AI-related semiconductor demand, which beat expectations. However, cautious Q4 guidance, including EPS below analyst estimatesTradingKey
17 hours ago
.jpg)
Bridgewater Associates Q2 2025 13F Analysis: Founder Ray Dalio’s Final Act
TradingKey - Bridgewater Associates, the world’s largest hedge fund and renowned for its macroeconomic analysis, continues to command market respect with its “risk parity” strategy and precise economic cycle timing.TradingKey
Thu, Aug 14
Ethereum Price Prediction: Will ETH Extend the Rally? What’s the Future Trend?
Ethereum's impressive 2025 rally has been largely fueled by inflows from spot ETFs and a surge in institutional holdings, signaling growing confidence in its role as a core asset in the crypto market. However, to officially confirm the start of a new bull cycle, ETH must break above the critical $4,TradingKey
Wed, Jul 23
